Your browser doesn't support javascript.
loading
Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer-retrospective analysis of response.
Nguyen, Khanh T; Kalyan, Aparna; Beasley, H Scott; Singhi, Aatur D; Sun, Weijing; Zeh, Herbert J; Normolle, Daniel; Bahary, Nathan.
  • Nguyen KT; Department of Hematology and Oncology, University of Pittsburgh, Pennsylvania, USA.
  • Kalyan A; Developmental Therapeutics Program of Department of Hematology and Oncology, Northwestern University, Illinois, USA.
  • Beasley HS; Department of Radiology, University of Pittsburgh, Pennsylvania, USA.
  • Singhi AD; Department of Pathology, University of Pittsburgh, Pennsylvania, USA.
  • Sun W; Department of Hematology and Oncology, University of Pittsburgh, Pennsylvania, USA.
  • Zeh HJ; Division of Gastrointestinal Surgical Oncology, University of Pittsburgh, Pennsylvania, USA.
  • Normolle D; Department of Biostatistics, University of Pittsburgh, Pennsylvania, USA.
  • Bahary N; Department of Hematology and Oncology, University of Pittsburgh, Pennsylvania, USA.
J Gastrointest Oncol ; 8(3): 556-565, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28736642
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2017 Tipo del documento: Article